463 related articles for article (PubMed ID: 27068665)
1. Pain Control in the Presence of Drug Addiction.
Vadivelu N; Lumermann L; Zhu R; Kodumudi G; Elhassan AO; Kaye AD
Curr Pain Headache Rep; 2016 May; 20(5):35. PubMed ID: 27068665
[TBL] [Abstract][Full Text] [Related]
2. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for Substance Abuse and Pain Control in Patients with Chronic Pain.
Vadivelu N; Kai AM; Kodumudi G; Haddad D; Kodumudi V; Kuruvilla N; Kaye AD; Urman RD
Curr Pain Headache Rep; 2018 Mar; 22(4):25. PubMed ID: 29556830
[TBL] [Abstract][Full Text] [Related]
4. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
Gasior M; Bond M; Malamut R
Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
[TBL] [Abstract][Full Text] [Related]
5. National drug control policy and prescription drug abuse: facts and fallacies.
Manchikanti L
Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
[TBL] [Abstract][Full Text] [Related]
6. Assessing the impact of abuse-deterrent opioids (ADOs): identifying epidemiologic factors related to new entrants with low population exposure.
Roland CL; Setnik B; Brown DA
Postgrad Med; 2017 Jan; 129(1):12-21. PubMed ID: 27960575
[TBL] [Abstract][Full Text] [Related]
7. Abuse-deterrent formulations of prescription opioid analgesics in the management of chronic noncancer pain.
Hale ME; Moe D; Bond M; Gasior M; Malamut R
Pain Manag; 2016 Oct; 6(5):497-508. PubMed ID: 27050830
[TBL] [Abstract][Full Text] [Related]
8. Prescription Opioid Misuse, Abuse, Morbidity, and Mortality: Balancing Effective Pain Management and Safety.
Cheatle MD
Pain Med; 2015 Oct; 16 Suppl 1():S3-8. PubMed ID: 26360931
[TBL] [Abstract][Full Text] [Related]
9. Opioid addiction, diversion, and abuse in chronic and cancer pain.
Kata V; Novitch MB; Jones MR; Anyama BO; Helander EM; Kaye AD
Curr Opin Support Palliat Care; 2018 Jun; 12(2):124-130. PubMed ID: 29465470
[TBL] [Abstract][Full Text] [Related]
10. What percentage of chronic nonmalignant pain patients exposed to chronic opioid analgesic therapy develop abuse/addiction and/or aberrant drug-related behaviors? A structured evidence-based review.
Fishbain DA; Cole B; Lewis J; Rosomoff HL; Rosomoff RS
Pain Med; 2008; 9(4):444-59. PubMed ID: 18489635
[TBL] [Abstract][Full Text] [Related]
11. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.
Webster LR; Markman J; Cone EJ; Niebler G
Postgrad Med; 2017 Jan; 129(1):102-110. PubMed ID: 27915497
[TBL] [Abstract][Full Text] [Related]
12. Long-term opioid therapy for chronic non-cancer pain in Germany.
Marschall U; L'hoest H; Radbruch L; Häuser W
Eur J Pain; 2016 May; 20(5):767-76. PubMed ID: 26492066
[TBL] [Abstract][Full Text] [Related]
13. Pain volatility and prescription opioid addiction treatment outcomes in patients with chronic pain.
Worley MJ; Heinzerling KG; Shoptaw S; Ling W
Exp Clin Psychopharmacol; 2015 Dec; 23(6):428-35. PubMed ID: 26302337
[TBL] [Abstract][Full Text] [Related]
14. The opioid crisis: a 21st century pain.
Walker G
Drugs Today (Barc); 2018 Apr; 54(4):283-286. PubMed ID: 29869649
[TBL] [Abstract][Full Text] [Related]
15. Tamper-resistant opioid formulations in the treatment of acute pain.
Passik SD
Adv Ther; 2014 Mar; 31(3):264-75. PubMed ID: 24526323
[TBL] [Abstract][Full Text] [Related]
16. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.
Sehgal N; Manchikanti L; Smith HS
Pain Physician; 2012 Jul; 15(3 Suppl):ES67-92. PubMed ID: 22786463
[TBL] [Abstract][Full Text] [Related]
17. Chronic pain, addiction severity, and misuse of opioids in Cumberland County, Maine.
Heimer R; Dasgupta N; Irwin KS; Kinzly M; Harvey AP; Givens A; Grau LE
Addict Behav; 2012 Mar; 37(3):346-9. PubMed ID: 22138379
[TBL] [Abstract][Full Text] [Related]
18. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
19. The Clinical Applications of Extended-Release Abuse-Deterrent Opioids.
Vadivelu N; Schermer E; Kodumudi G; Berger JM
CNS Drugs; 2016 Jul; 30(7):637-46. PubMed ID: 27290716
[TBL] [Abstract][Full Text] [Related]
20. Prescription opioid abuse, pain and addiction: clinical issues and implications.
Ling W; Mooney L; Hillhouse M
Drug Alcohol Rev; 2011 May; 30(3):300-5. PubMed ID: 21545561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
